Cardiovascular Business -- Pfizer has received European Union approval for a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes.
